Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with …

…, F Cons-Molina, SD Barragan, C Skinner, CP Tena… - The Lancet, 2018 - thelancet.com
Background Biological disease-modifying anti-rheumatic drugs (bDMARDs) are recommended
for radiographic axial spondyloarthritis, otherwise known as ankylosing spondylitis, when …

Update of the Mexican College of Rheumatology guidelines for the pharmacologic treatment of rheumatoid arthritis

…, JI Gámez-Nava, LAB Fabris, CP Tena… - … Clínica (English Edition), 2014 - Elsevier
Background The pharmacologic management of rheumatoid arthritis has progressed
substantially over the past years. It is therefore desirable that existing information be periodically …

Subcutaneous abatacept for the treatment of rheumatoid arthritis: longterm data from the ACQUIRE trial

MC Genovese, CP Tena, A Covarrubias… - The Journal of …, 2014 - jrheum.org
Objective. Assess longterm tolerability, safety, and efficacy of subcutaneous (SC) abatacept (ABA)
in methotrexate-refractory patients with rheumatoid arthritis (RA). Methods. The phase …

Update of the Mexican College of Rheumatology guidelines for the pharmacological treatment of rheumatoid arthritis, 2018

…, S Carrillo, M Pérez, L Andrade, CP Tena… - … Clínica (English Edition), 2021 - Elsevier
Therapeutic advances in rheumatoid arthritis require periodic review of treatment guidelines.
Objective To update the Mexican College of Rheumatology guidelines on the …

Actualización de la Guía mexicana para el tratamiento farmacológico de la artritis reumatoide del Colegio Mexicano de Reumatología

…, JI Gámez-Nava, LAB Fabris, CP Tena… - Reumatología …, 2014 - Elsevier
Antecedentes El manejo de la artritis reumatoide ha tenido avances muy importantes en los
últimos años. Las guías de práctica clínica requieren una actualización constante. …

Actualización de las guías del tratamiento farmacológico de la artritis reumatoide del Colegio Mexicano de Reumatología 2018

…, S Carrillo, M Pérez, L Andrade, CP Tena… - Reumatología …, 2021 - Elsevier
Los avances terapéuticos en la artritis reumatoide obligan a revisión periódica de las guías
de tratamiento. Objetivo Actualizar las guías del Colegio Mexicano de Reumatología del …

Síndrome de hiperuricemia: Una perspectiva fisiopatológica integrada

VAR Barrera, CP Tena, A Nevárez-Rascón… - Archivos de …, 2020 - dialnet.unirioja.es
El síndrome hiperuricémico es relativamente común en el ser humano, ya que afecta a casi
una cuarta parte de la población, con una predominancia en los varones 3 a 4 veces mayor …

P060 Screening Criteria of Inflammatory Bowel Disease: Application in Colombian Patients With Spondyloarthritis

…, AR Casallas, LC Moreno, CP Tena… - Official journal of the …, 2021 - journals.lww.com
BACKGROUND: The Spondyloarthritis (SpA) is a group of chronic inflammatory rheumatic
diseases, in which 5-10% of extra-articular manifestations are gastrointestinal such as the …

P050 Oral Inflammatory Changes Associated With Inflammatory Bowel Disease in Spondyloarthritis Associated With Early Endoscopic Findings

…, J De Avila, J Bello, D Jaimes, CP Tena… - Official journal of the …, 2021 - journals.lww.com
BACKGROUND: Spondyloarthritis (SpA) is a heterogeneous group of chronic autoinflammatory
disorders that can present extra-articular gastrointestinal manifestations. Among them is …

[HTML][HTML] Intestinal inflammation marker calprotectin regulates epithelial intestinal zinc metabolism and proliferation in mouse jejunal organoids

…, D Ceacero-Heras, M Tena-Garitaonaindia… - Biomedicine & …, 2024 - Elsevier
… Overall, CP exerts modulatory effects in murine jejunal organoids that are in part related to
Zn 2+ sequestration and partially reproduced in vivo, supporting the validity of mouse jejunal …